FY24 precisionFDA IDIQ 6 month Extension

The Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services has issued a Special Notice regarding a sole source modification to increase the ceiling of an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract 75F40119D10041 from $20,000,000.00 to $23,036,960.56. This action will allow for a non-competitive, 6-month task order award to continue providing support for the precisionFDA system, an open-source, cloud-based regulatory science research platform.

The purpose of this Special Notice is to inform interested parties of the FDA's intent to issue a sole source modification to the existing IDIQ contract held by DNAnexus, the only vendor able to meet the FedRAMP Moderate and FISMA Moderate security requirements. The modification will enable a short-term, 6-month task order to be awarded without competition due to unexpected, last-minute funding. The agency has determined that transitioning to a new vendor would be too costly and time-consuming. Interested parties may identify their capability or address any inquiries by responding to the Contract Specialist prior to 3:00PM Eastern Standard Time on September 20, 2024, but no reimbursement for costs will be provided.